Antiphospholipid syndrome (APS) is the association of thrombosis and/or pregnancy
morbidity with antiphospholipid antibodies (aPL). Thirty to forty percent of systemic lupus …

Connective tissue diseases (CTDs) are a heterogeneous group of disorders that share
certain clinical presentations and a disturbed immunoregulation, leading to autoantibody …

Kidney damage is a well-recognized complication of the antiphospholipid syndrome (APS),
either primary or systemic lupus erythematosus (SLE)-associated APS. Kidney involvement …

Antiphospholipid antibody syndrome (APLS) is a rare autoimmune disease characterized by
recurrent arterial and venous thromboembolic events, pregnancy related complications as …

Antiphospholipid syndrome (APS) is an autoimmune disease defined by the presence of
arterial or venous thrombotic events and/or pregnancy morbidity in patients who test positive …

Renal Involvement in Primary Antiphospholipid Syndrome: Retr... : Clinical Journal of the
American Society of Nephrology Renal Involvement in Primary Antiphospholipid Syndrome …

Antiphospholipid syndrome is a complex autoimmune disease, characterized by the
presence of vascular thrombosis, obstetric, hematologic, cutaneous, and cardiac …

Although the kidney represents a major target organ in antiphospholipid syndrome (APS),
renal involvement in APS was poorly recognized until recently. The most well-recognized …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by
thrombosis, pregnancy morbidity, or non-thrombotic manifestations in patients with …

Background APS is a systemic autoimmune disease characterized by a spectrum of clinical
phenotypes, including macrovascular and microvascular thrombosis, pregnancy morbidity …